Pulse Biosciences PLSE
NASDAQ PLSE
$49.83 -0.09 (-0.18%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pulse Biosciences (PLSE) EBITDA Margin (2021 - 2025)

Updated

Pulse Biosciences (PLSE) reported EBITDA Margin of -6815.91% for Q4 2025, up 16557.35 percentage points from the prior quarter.

Analysis

Pulse Biosciences (PLSE) EBITDA Margin (2021 - 2025) Analysis & Trends

For FY2025, Pulse Biosciences posted EBITDA Margin of -21676.57%.

  • EBITDA Margin has a four-year change of -17314.94 percentage points (FY2021 to FY2025).
  • By year, EBITDA Margin came in at -8098.86% in FY2022 (-3737.22 pp) and -4361.64% in FY2021.
  • The Q4 2025 figure ranks as the highest quarterly EBITDA Margin since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 21.86%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 41.08%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 25.55%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 31.93%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 24.62%
10 Pulse Biosciences 3.53 Bn 3.53 Bn 161,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -6,815.91%
Sep 30, 2025 -23,373.26%
Jun 30, 2022 -4,582.33%
Mar 31, 2022 -3,807.88%
Dec 31, 2021 -1,788.27%
Sep 30, 2021 -2,440.07%
API Access

Pulse Biosciences EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PLSE&period=max&api_key=YOUR_API_KEY